Liliana Halip

According to our database, Liliana Halip authored at least 7 papers between 2007 and 2024.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of three.

2024

Correction: Exploring DrugCentral: from molecular structures to clinical effects.

Liliana Halip, Sorin I. Avram, Ramona Curpan, Ana Borota, Alina Bora, Cristian Bologa, Tudor I. Oprea

J. Comput. Aided Mol. Des., December, 2024

2023

Exploring DrugCentral: from molecular structures to clinical effects.

Liliana Halip, Sorin I. Avram, Ramona Curpan, Ana Borota, Alina Bora, Cristian Bologa, Tudor I. Oprea

J. Comput. Aided Mol. Des., December, 2023

DrugCentral 2023 extends human clinical data and integrates veterinary drugs.

Sorin I. Avram, Thomas B. Wilson, Ramona Curpan, Liliana Halip, Ana Borota, Alina Bora, Cristian Bologa, Jayme Holmes, Jeffrey Knockel, Jeremy J. Yang, Tudor I. Oprea

Nucleic Acids Res., January, 2023

2021

DrugCentral 2021 supports drug discovery and repositioning.

Sorin I. Avram, Cristian Bologa, Jayme Holmes, Giovanni Bocci, Thomas B. Wilson, Dac-Trung Nguyen, Ramona Curpan, Liliana Halip, Alina Bora, Jeremy J. Yang, Jeffrey Knockel, Suman Sirimulla, Oleg Ursu, Tudor I. Oprea

Nucleic Acids Res., 2021

2020

Off-Patent Drug Repositioning.

Sorin I. Avram, Ramona Curpan, Liliana Halip, Alina Bora, Tudor I. Oprea

J. Chem. Inf. Model., 2020

2018

Modeling Kinase Inhibition Using Highly Confident Data Sets.

Sorin I. Avram, Alina Bora, Liliana Halip, Ramona Curpan

J. Chem. Inf. Model., 2018

2007

Lead-like, drug-like or "Pub-like": how different are they?

Tudor I. Oprea, Tharun Kumar Allu, Dan C. Fara, Ramona F. Rad, Liliana Ostopovici, Cristian Bologa

J. Comput. Aided Mol. Des., 2007